CLBS - Spark Newswire

5 minute read

Why Vintage Wine Estates Shares Tumbled 40%; Here Are 70 Biggest Movers From Yesterday

September 15, 5:21 AM

Gainers AMTD Digital Inc. (NYSE: HKD) shares jumped 311.8% to settle at $189.42 on Wednesday as the stock experienced a resurgence in momentum despite a lack of fundamental news.

2 minute read

Movers

12 Health Care Stocks Moving In Wednesday’s Intraday Session

By Benzinga Insights

September 14, 1:33 PM

ALT

2 minute read

News

Caladrius Biosciences Announces Approval Of Merger And Name Change To Lisata Therapeutics

By Benzinga Newsdesk

September 14, 8:11 AM

BASKING RIDGE, N.J., Sept. 14, 2022 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (NASDAQ:CLBS) ("Caladrius" or the "Company"), announced today that, based upon the final vote count certified by the

CLBS

1 minute read

Movers

12 Health Care Stocks Moving In Friday’s Pre-Market Session

By Benzinga Insights

September 2, 8:07 AM

ADMA

3 minute read

Why Pagerduty Is Trading Higher By 9%; Here Are 28 Stocks Moving Premarket

By Lisa Levin

September 2, 6:26 AM

Gainers

AMPE

4 minute read

Biotech Daily: Cancer Causing Impurities In Merck’s Diabetic Drug, Vir Bio-GSK Shun FDA Submission Plans For COVID-19 Treatment, Aethlon’s Monkeypox Trial

By Vandana Singh

August 10, 11:33 AM

Here's a roundup of top developments in the biotech space over the last 24 hours:

ADMP

1 minute read

Caladrius Biosciences Q2 EPS $(0.11) Misses $(0.10) Estimate

By Bill Haddad

August 4, 5:39 PM

Caladrius Biosciences (NASDAQ:CLBS) reported quarterly losses of $(0.11) per share which missed the analyst consensus estimate of $(0.10) by 10 percent. This is a 10 percent decrease over losses of $(0.10) per share from

CLBS

34 minute read

Earnings

Earnings Scheduled For August 4, 2022

By Benzinga Insights

August 4, 4:23 AM

Companies Reporting Before The Bell • Toyota Motor (NYSE:TM) is projected to report earnings for its first quarter.

AAOI

1 minute read

Earnings

Earnings Outlook For Caladrius Biosciences

By Benzinga Insights

August 3, 1:18 PM

Caladrius Biosciences (NASDAQ:CLBS) is set to give its latest quarterly earnings report on Thursday, 2022-08-04. Here's what investors need to know before the announcement. Analysts estimate that Caladrius Biosciences will report an earnings per share (EPS) of $-0.10.

CLBS